Key result
A 23-year-old nulliparous woman developed severe non-ischemic cardiomyopathy with an ejection fraction of 10-15% six weeks after an asymptomatic COVID-19 infection.
Case Report (n=1)
Severe non-ischemic cardiomyopathy can occur as a post-infectious sequela several weeks after an asymptomatic COVID-19 infection, even in young patients without prior cardiac history.
Answers are grounded in this paper and cite their sources.
Delayed post-COVID non-ischemic cardiomyopathy reported in young nulliparous woman; leaves open causal link and need for prospective confirmation.
A young nulliparous woman presented with new-onset heart failure several weeks after an asymptomatic coronavirus disease 2019 (COVID-19) infection. Investigation revealed non-ischemic cardiomyopathy without apical ballooning. A literature review demonstrates other reported cases of COVID-19-induced cardiomyopathy; however, our patient was demographically unique from previously described cases, presented later, and did not have Takotsubo-like findings. Our patient continued to have evidence of cardiac remodeling and a reduced ejection fraction months after presentation. This case highlights the importance of surveilling for the post-infectious sequelae of COVID-19, along with the wide demographic range of patients susceptible to such outcomes.
No takes yet. Share an insight, caveat, or question.
Chenevey et al. (2021) conducted a case report in COVID-19-induced cardiomyopathy (n=1). COVID-19 infection was evaluated on Development of non-ischemic cardiomyopathy. A 23-year-old nulliparous woman developed severe non-ischemic cardiomyopathy with an ejection fraction of 10-15% six weeks after an asymptomatic COVID-19 infection.
Synapse has enriched 10 related papers. Consider them for comparative context: